ArticleIn vitro cellular & developmental biology. Animal2026
Quantitative evaluation of SLAM receptor-mediated enhancement in canine distemper virus detection: insights from viability, AUC, and MED analyses.
Article in In vitro cellular & developmental biology. Animal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canine distemper virus (CDV), a highly contagious member of the Morbillivirus genus in the Paramyxoviridae family, continues to threaten the health of domestic and wild carnivores worldwide. However, isolation of field strains is often limited by the low susceptibility of conventional cell lines lacking essential viral entry receptors. In this study, a recombinant Vero cell line stably expressing the canine signaling lymphocyte activation molecule (SLAM/CD150) receptor was established to improve CDV isolation efficiency. The SLAM gene was amplified from canine peripheral blood mononuclear cells (PBMCs), cloned into the pTargeT mammalian expression vector, and transfected into Vero cells. Functional expression of SLAM was validated by inoculation with a field isolate (CDV34388), which induced pronounced cytopathic effects and extensive syncytium formation in Vero-dogSLAM cells, whereas no syncytia were observed in non-transfected controls. Quantitative analyses revealed a mean 2.8-fold increase in minimum effective dilution (MED) values and an average area-under-the-curve (ΔAUC) of + 98 units in SLAM-expressing cells compared with normal Vero cells (p < 0.001), indicating markedly enhanced viral replication and cytopathic activity. These findings demonstrate that canine SLAM expression significantly improves CDV detection and isolation from field samples, establishing a robust in vitro model for future diagnostic and vaccine development studies.
Indexed as
Identifiers
41533316What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.